Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 252-813-7 | CAS number: 35948-25-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Start of preliminary test: 04 May 2011; Start of experiment: 18 May 2011; End of experiment: 24 May 2011
- Reliability:
- 1 (reliable without restriction)
- Justification for data waiving:
- other:
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/J Rj
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source:
Elevage Janvier,
Route des Chènes Secs B.P. 4105,
53940 Le Genest-St-Isle,
France
- Age at study initiation: 9-10 weeks old (Female, nulliparous, non pregnant)
- Weight at study initiation: 21.1 – 22.7 g (The weight variation in animals involved in the study did not exceed ± 20 % of the mean weight)
- Housing:
Housing / Enrichment: Group caging / mice were provided with glass tunnel-tubes
Cage type: Type II. polypropylene/ polycarbonate
Bedding: Bedding was available to animals during the study
- Diet (e.g. ad libitum): Animals received ssniff SM R/M-Z+H "Autoclavable complete diet for rats and mice - breeding and maintenance" (Batch number: 555 5267 Expiry Date: August 2011) produced by ssniff Spezialdiaten GmbH (Ferdinand-Gabriel-Weg 16, D-59494 Soest, Germany), ad libitum.
- Water (e.g. ad libitum): Animals received tap water from the municipal supply from 500 ml bottle, ad libitum. Water quality control analysis was performed once every three months and microbiological assessment was performed monthly, by Veszprém County Institute of State Public Health and Medical Officer Service (ÁNTSZ, H-8201 Veszprém, József A.u.36., Hungary). Copies of the relevant Certificates of Analysis are retained in the Archive at LAB Research Ltd.
- Acclimation period: 13 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±3
- Humidity (%): 30-70
- Air changes (per hr): 15-20
- Photoperiod (hrs dark / hrs light): Light - 12 hours daily, from 6.00am to 6.00pm - Vehicle:
- dimethylformamide
- Remarks:
- N,N-dimethylformamide
- Concentration:
- 25, 10 and 5 (w/v)%
- No. of animals per dose:
- 4 animals/treatment group
- Details on study design:
- RANGE FINDING TESTS: The Preliminary Irritation/Toxicity Test was performed in CBA/J Rj mice using two doses (test item concentrations of 25 and 10 (w/v) %) in the selected vehicle. The observations recorded in the preliminary test suggest that the 25 (w/v)% formulation is a suitable dose level for a valid LLNA. See Appendix of attached report for results of preliminary irritation/toxicity test.
MAIN STUDY:
ANIMAL ASSIGNMENT AND TREATMENT
- Identification: A unique number written on the tail with a permanent marker identified each animal. The animal number was assigned on the basis of LAB Research Ltd’s master file. The cages were marked with identity cards with information including study code, cage number, and dose group, sex and individual animal number. The animals were randomised and allocated to the experimental groups. The randomisation was checked by computer software according to the actual body weights, verifying the homogeneity and variability between the groups.
TREATMENT PREPARATION AND ADMINISTRATION:
- ADMINISTRATION OF THE TEST ITEM
- Topical application: During the assay each mouse was topically dosed on the dorsal surface of each ear with 25 µl of the appropriate formulation applied using a pipette. Each animal was dosed once a day for three consecutive days (Days 1, 2 and 3). There was no treatment on Days 4, 5 and 6. - Positive control substance(s):
- other: α-Hexylcinnamaldehyde, ≥95%
- Positive control results:
- Positive control 25% α-HCA in DMF:
Measured DPM/Group: 14806
Group DPM: 14764.5
No. of Nodes: 8
DPN: 1845.6
Stimulation Index Values: 16.6 - Parameter:
- SI
- Remarks on result:
- other: Negative control DMF: 1.0 HCA 25 (w/v)% in DMF: 2.5 HCA 10 (w/v)% in DMF: 4.4 HCA 5 (w/v)% in DMF: 4.2 Positive control 25% α-HCA in DMF: 16.6
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- Measured DPM/group: Background (5 (w/v)% TCA): 41.5 Negative control DMF: 931 HCA 25 (w/v)% in DMF: 2278 HCA 10 (w/v)% in DMF: 3974 HCA 5 (w/v)% in DMF: 3804 Positive control 25 % α-HCA in DMF: 14806 Group DPM: Negative control DMF: 889.5 HCA 25 (w/v)% in DMF: 2236.5 HCA 10 (w/v)% in DMF: 3932.5 HCA 5 (w/v)% in DMF: 3762.5 Positive control 25% α-HCA in DMF: 14764.5
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In conclusion, under the conditions of the present assay HCA (Batch No.: 00423), tested in a suitable vehicle, was shown to have a sensitization potential (sensitizer) in the Local Lymph Node Assay.
- Executive summary:
The aim of this study was to determine the skin sensitization potential of HCA following dermal exposure.
Based on the results of the Preliminary Compatibility Test and on the recommendations of the OECD Guideline [1], the test item was dissolved in N,N-dimethylformamide (abbreviation: DMF). The test item formed an appropriate formulation in this vehicle at concentrations of 25 (w/v)%, therefore it was chosen as vehicle for the test.
The Preliminary Irritation/Toxicity Test was performed in CBA/J Rj mice using two doses (test item concentrations of 25 and 10 (w/v)%) in the selected vehicle. The observations recorded in the preliminary test suggest that the 25 (w/v)% formulation is a suitable dose level for a valid LLNA.
In the main assay, sixteen female CBA/J Rj mice were allocated to four groups of four animals each:
- three groups received the appropriate formulation of HCA at concentrations of 25, 10 and 5 (w/v)%,
- the negative control group received DMF,
- the positive control group* received 25% α-Hexylcinnamaldehyde (α-HCA) in DMF.
*To minimise animal use, the positive control group was part of a concurrent study with the same solvent.
The solutions of the test item were applied on the dorsal surface of ears of days (Days 1, 2 and 3). There was no treatment on Days 4, 5 and 6. On Day 6, the cell proliferation in the local lymph nodes was measured by incorporation of tritiated methyl thymidine (3HTdR) and the values obtained were used to calculate stimulation indices (SI).
No mortality, systemic toxicity or local irritation was observed during the study. No treatment related effects were observed on animal body weights in any other treated groups. The observed clinical signs are summarized in Appendix 3 of attached report.
Stimulation index values of the test item were 2.5, 4.4 and 4.2 at treatment concentrations of 25, 10 and 5 (w/v)%, respectively.
α-Hexylcinnamaldehyde (25 (w/v)% dissolved in DMF) was used as a positive control to demonstrate the appropriate performance of the assay [1]. A significant lymphoproliferative response (stimulation index value of 16.6) was noted for the positive control chemical and this result confirmed the validity of the assay.
In conclusion, under the conditions of the present assay HCA (Batch No.: 00423), tested in a suitable vehicle, was shown to have a sensitization potential (sensitizer) in the Local Lymph Node Assay.
Reference
CLINICAL OBSERVATION: No mortality or signs of systemic toxicity were observed during the study, no local dermal effects were seen at the site of application. The results are given in Appendix 3 of attached report.
BODY WEIGHT MEASUREMENT: No treatment related effects were observed on animal body weights. Individual and mean body weights are given in Table 3 of attached report.
PROLIFERATION ASSAY: The results of the proliferation assay are summarized in Table 4 and Figure 1 of the attached report. Appearance of the lymph nodes was normal in the negative control group and in the test item treated groups. Larger than normal lymph nodes was observed in the positive control group in the 25 and 10 (w/v)% treated groups.
INTERPRETATION OF OBSERVATIONS: The test item was a white powder, which was dissolved in N,N-dimethylformamide.
Since there were no confounding effects of irritation or systemic toxicity at the applied concentrations, the proliferation values obtained are considered to reflect the real potential of the test item to cause lymphoproliferation in the Local Lymph Node Assay. A significant lymphoproliferative response (SI≥3) was noted for HCA at concentrations of 10 and 5 (w/v)%. Stimulation index values of the test item were 2.5, 4.4 and 4.2 at treatment concentrations of 25, 10 and 5 (w/v)%, respectively (Figure 1 of attached report).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
- Migrated from Short description of key information:
Under the conditions of the present assay HCA (Batch No.: 00423), tested in a suitable vehicle, was shown to have a sensitization potential (sensitizer) in the Local Lymph Node Assay.
[1] OECD Guidelines for Testing of Chemicals No. 429. Skin Sensitisation: Local Lymph Node Assay. Adopted: 22 July 2010.
Justification for selection of skin sensitisation endpoint:
In conclusion, under the conditions of the present assay HCA (Batch No.: 00423), tested in a suitable vehicle, was shown to have a sensitization potential (sensitizer) in the Local Lymph Node Assay.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.